Anne‐Pierre Morel

3.7k total citations · 1 hit paper
27 papers, 2.7k citations indexed

About

Anne‐Pierre Morel is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Anne‐Pierre Morel has authored 27 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Anne‐Pierre Morel's work include Cancer Cells and Metastasis (11 papers), Epigenetics and DNA Methylation (9 papers) and Cancer Genomics and Diagnostics (6 papers). Anne‐Pierre Morel is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Epigenetics and DNA Methylation (9 papers) and Cancer Genomics and Diagnostics (6 papers). Anne‐Pierre Morel collaborates with scholars based in France, United States and Italy. Anne‐Pierre Morel's co-authors include Alain Puisieux, Stéphane Ansieau, George Hinkal, Clémence Thomas, Laura Corbo, Jean‐Pierre Magaud, Marie-Claude Rostan, Thibault Voeltzel, Déborah Prévôt and Ruth Rimokh and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Anne‐Pierre Morel

26 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition

2008 1.3k citations Anne‐Pierre Morel, Clémence Thomas et al. PLoS ONE profile →

Peers

Countries citing papers authored by Anne‐Pierre Morel

Since Specialization

Citations

This map shows the geographic impact of Anne‐Pierre Morel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Pierre Morel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Pierre Morel more than expected).

Fields of papers citing papers by Anne‐Pierre Morel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Pierre Morel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Pierre Morel. The network helps show where Anne‐Pierre Morel may publish in the future.

Co-authorship network of co-authors of Anne‐Pierre Morel

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Pierre Morel. A scholar is included among the top collaborators of Anne‐Pierre Morel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Pierre Morel. Anne‐Pierre Morel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Understanding cancer cell plasticity: EMT, respecialisation, and therapeutic opportunities 2025 ·EMBO Molecular Medicine ·Anne‐Pierre Morel, Maria Ouzounova	0
2	Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial-to-mesenchymal plasticity 2024 ·Science Advances ·(unknown), Laurie Tonon, Frédérique Fauvet, Roxane M. Pommier, (unknown), (unknown), Francesca Angileri, Benjamin Gibert, Raphaël Rodriguez, Maria Ouzounova, Anne‐Pierre Morel, Alain Puisieux	7
3	Spatial Transcriptomics Reveal Pitfalls and Opportunities for the Detection of Rare High-Plasticity Breast Cancer Subtypes 2023 ·Laboratory Investigation ·(unknown), Vincent Cockenpot, (unknown), Cyril Dégletagne, Roxane M. Pommier, Laurie Tonon, Maude Ardin, Marie‐Cécile Michallet, Christophe Caux, Marie Laurent, Anne‐Pierre Morel, Pierre Saintigny, Alain Puisieux, Maria Ouzounova, Pierre Martinez	10
4	Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis 2021 ·Cancers ·(unknown), Anne‐Pierre Morel, (unknown), Maria Ouzounova, Alain Puisieux	47
5	Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution 2020 ·Nature Communications ·Roxane M. Pommier, Amélien Sanlaville, Laurie Tonon, Janice Kielbassa, Emilie Thomas, Anthony Ferrari, Anne-Sophie Sertier, Frédéric Hollande, Pierre Martinez, Agnès Tissier, Anne‐Pierre Morel, Maria Ouzounova, Alain Puisieux	68
6	Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 2015 ·Nucleic Acids Research ·Guillaume Devailly, (unknown), (unknown), (unknown), Jean‐Guy Delcros, Yannick Bidet, Anne‐Pierre Morel, (unknown), Alain Puisieux, Patrick Mehlen, Robert Dante	20
7	A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage 2015 ·OncoImmunology ·Colette Dezutter‐Dambuyant, Isabelle Durand, Laurent Alberti, Nathalie Bendriss‐Vermare, Jenny Valladeau‐Guilemond, Adeline Duc, (unknown), Anne‐Pierre Morel, Vanja Sisirak, Céline Rodriguez, David G. Cox, D Olive, Christophe Caux	74
8	Deregulation of miR-183 and KIAA0101 in Aggressive and Malignant Pituitary Tumors 2015 ·Frontiers in Medicine ·Magali Roche, Anne Wierinckx, Séverine Croze, Catherine Rey, Catherine Legras‐Lachuer, Anne‐Pierre Morel, Alfredo Fusco, Gérald Raverot, Jacqueline Trouillas, Joël Lachuer	35
9	ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells 2014 ·Molecular Cancer ·F. Leccia, Luigi Del Vecchio, (unknown), Rosa Di Noto, Anne‐Pierre Morel, Alain Puisieux, Francesco Salvatore, Stéphane Ansieau	30
10	EMT Inducers Catalyze Malignant Transformation of Mammary Epithelial Cells and Drive Tumorigenesis towards Claudin-Low Tumors in Transgenic Mice 2012 ·PLoS Genetics ·Anne‐Pierre Morel, George Hinkal, Clémence Thomas, Frédérique Fauvet, Stéphanie Courtois-Cox, Anne Wierinckx, Mojgan Devouassoux‐Shisheboran, Isabelle Treilleux, Agnès Tissier, Baptiste Gras, (unknown), Isabelle Puisieux, Gareth J. Browne, Douglas B. Spicer, Joël Lachuer, Stéphane Ansieau, Alain Puisieux	150
11	Failsafe program escape and EMT: A deleterious partnership 2011 ·Seminars in Cancer Biology ·Stéphane Ansieau, Stéphanie Courtois-Cox, Anne‐Pierre Morel, Alain Puisieux	23
12	Antagonistic regulation of EMT by TIF1γ and Smad4 in mammary epithelial cells 2011 ·EMBO Reports ·Cédric Hesling, Laurent Fattet, (unknown), (unknown), Philippe Gonzalo, Jonathan Lopez, Christophe Vanbelle, Anne‐Pierre Morel, Germain Gillet, Ivan Mikaélian, Ruth Rimokh	58
13	TWISTing an embryonic transcription factor into an oncoprotein 2010 ·Oncogene ·Stéphane Ansieau, Anne‐Pierre Morel, George Hinkal, Jérémy Bastid, Alain Puisieux	134
14	Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition breakdown → 2008 ·PLoS ONE ·Anne‐Pierre Morel, (unknown), Clémence Thomas, George Hinkal, Stéphane Ansieau, Alain Puisieux	1283
15	CCR4-Associated Factor CAF1 Is an Essential Factor for Spermatogenesis 2004 ·Molecular and Cellular Biology ·Cyril Berthet, (unknown), (unknown), Marie‐Agnès Chauvin, Anne‐Pierre Morel, Frédérique Dijoud, Jean‐Pierre Magaud, (unknown), (unknown)	84
16	Identification of four families of yCCR4- and Mg2+-dependent endonuclease-related proteins in higher eukaryotes, and characterization of orthologs of yCCR4 with a conserved leucine-rich repeat essential for hCAF1/hPOP2 binding 2001 ·BMC Genomics ·Anne Dupressoír, Anne‐Pierre Morel, (unknown), (unknown), Laura Corbo, Thiérry Heidmann	117
17	Relationships of the Antiproliferative Proteins BTG1 and BTG2 with CAF1, the Human Homolog of a Component of the Yeast CCR4 Transcriptional Complex 2001 ·Journal of Biological Chemistry ·Déborah Prévôt, Anne‐Pierre Morel, Thibault Voeltzel, Marie-Claude Rostan, Ruth Rimokh, Jean‐Pierre Magaud, Laura Corbo	109
18	BTG gene expression in the p53-dependent and -independent cellular response to DNA damage 2000 ·Molecular Carcinogenesis ·Ulrich Cortes, Caroline Moyret‐Lalle, Nicole Falette, (unknown), Fatiha El Ghissassi, (unknown), Anne‐Pierre Morel, Pierre Hainaut, Jean‐Pierre Magaud, Alain Puisieux	2
19	The Leukemia-associated Protein Btg1 and the p53-regulated Protein Btg2 Interact with the Homeoprotein Hoxb9 and Enhance Its Transcriptional Activation 2000 ·Journal of Biological Chemistry ·Déborah Prévôt, Thibault Voeltzel, Anne‐Marie Birot, Anne‐Pierre Morel, Marie-Claude Rostan, Jean‐Pierre Magaud, Laura Corbo	121
20	BTG gene expression in the p53-dependent and -independent cellular response to DNA damage 2000 ·Molecular Carcinogenesis ·Ulrich Cortes, Caroline Moyret‐Lalle, Nicole Falette, (unknown), Fatiha El Ghissassi, (unknown), Anne‐Pierre Morel, Pierre Hainaut, Jean‐Pierre Magaud, Alain Puisieux	82

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact